Hydroxyapatite is a naturally occurring mineral form of calcium apatite, with the chemical formula Ca5(PO4)3OH. It is the major mineral component of teeth and bones and has been widely used in orthopedic and dental applications due to its excellent biocompatibility and osteoconductivity. Hydroxyapatite enhances the fusion or fixation of implants to bones, stimulates new bone formation, and acts as a scaffold for bone formation.
The Global Hydroxyapatite Market is estimated to be valued at US$ 2761.23 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Hydroxyapatite market are West Pharmaceutical Services Inc., Berry Global Inc., Sartorius AG, Corning Inc., Gerresheimer AG, SCHOTT AG, Stevanato Group, AptarGroup Inc., SGD Pharma, Ompi – Stevanato Group, DWK Life Sciences, Nipro Corporation, Nolato AB, Terumo Corporation, Qosina Corp.
The growing geriatric population and rise in orthopedic and dental disorders are driving the demand for Hydroxyapatite Market Growth in orthopedic and dental applications. According to the United Nations, the number of people aged 60 years and older is expected to reach 2.1 billion by 2050.
Major companies are focusing on expanding their hydroxyapatite manufacturing facilities globally to strengthen their market position and cater to the growing demand from developed as well as emerging economies. For instance, Berkeley Advanced Biomaterials launched a new manufacturing plant in Germany in 2021 to double its hydroxyapatite production capacity and support the increase in global demand.
Market drivers
The increasing use of hydroxyapatite in orthopedic applications is a major driver propelling the growth of this market. Hydroxyapatite coatings are increasingly used on metallic and polymer implants to enhance bone formation and achieve faster fusion. They act as excellent scaffolds for new bone formation at the implant-bone interface. This has increased the demand for hydroxyapatite coatings on hip, knee, and dental implants.
Current geopolitical situation on the growth of the Hydroxyapatite market:
The global geopolitical situation has introduced uncertainties that are impacting the growth of the Hydroxyapatite market. Heightened tensions between major world powers such as the ongoing Russia-Ukraine conflict and US-China trade wars have disrupted supply chains and increased costs of raw materials and logistics. This is hindering the affordability and accessibility of Hydroxyapatite products globally. Manufacturing operations have also been affected as businesses struggle to obtain necessary inputs. Export-import regulations introduced by various countries aim to boost their domestic industries but create hurdles for international trade. This protectionism poses challenges for Hydroxyapatite companies relying on a global supply and demand network. Additionally, economic downturns resulting from political instability and uncertainty reduce discretionary spending on non-essential medical procedures that use Hydroxyapatite. To sustain growth momentum, companies must diversify their sourcing, production and marketing footprint across different regions. They also need to invest in R&D to develop innovative formulations and applications of Hydroxyapatite that enhance clinical benefits and cost-effectiveness. This will help create new demand drivers and make the industry less dependent on the volatile macroeconomic environment.
Get more insights on Hydroxyapatite Market